MHS Insider Trading
MHS | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at MHS provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2012-02-29 01:10 | 2012-02-27 | CASSIS JOHN L | Director | OPT+S | $68.00 | 16,000 | $1,088,000 | 27,400 | 0.0% |
| 2012-01-11 00:03 | 2012-01-06 | WILSON BLENDA J | Director | OPT+S | $60.00 | 3,500 | $210,000 | 29,900 | 0.0% |
| 2011-07-22 23:15 | 2011-07-21 | Kornwasser Laizer | Officer - SVP-Retail, Mail & Diabetes | OPT+S | $65.75 | 22,962 | $1,509,752 | 61,169 | 0.0% |
| 2011-07-22 23:15 | 2011-07-21 | SMITH JACK ALLEN | Officer - SVP, Chief Marketing Officer | OPT+S | $65.31 | 18,000 | $1,175,580 | 75,417 | 0.0% |
| 2011-07-22 23:15 | 2011-07-21 | PRINCIVALLE KARIN | Officer - SVP, Human Resources | OPT+S | $65.31 | 16,380 | $1,069,778 | 48,300 | 0.0% |
| 2011-07-22 23:15 | 2011-07-21 | WENTWORTH TIMOTHY C | Officer - Group Pres, Employer Accounts | OPT+S | $65.31 | 36,995 | $2,416,143 | 95,845 | 0.0% |
| 2011-07-22 23:15 | 2011-07-21 | Moriarty Thomas M | Officer - Gen'l Counsel & Secretary, SVP | OPT+S | $65.31 | 33,678 | $2,199,510 | 68,867 | 0.0% |
| 2011-07-22 23:15 | 2011-07-21 | DRISCOLL JOHN PATRICK | Officer - President - New Markets | OPT+S | $65.50 | 33,167 | $2,172,439 | 86,749 | 0.0% |
| 2011-05-03 23:06 | 2011-05-02 | PRINCIVALLE KARIN | Officer - SVP, Human Resources | OPT+S | $60.02 | 95,370 | $5,724,107 | 48,300 | 0.0% |
| 2011-05-03 23:06 | 2011-05-02 | WENTWORTH TIMOTHY C | Officer - Group Pres, Employer Accounts | SELL | $0.00 | 8,720 | $0 | 95,845 | -8.3% |
| 2011-03-03 16:42 | 2011-03-02 | EPSTEIN ROBERT S | Officer - Pres, Adv. Clinical Science | SELL | $63.00 | 35,312 | $2,224,656 | 113,529 | -23.7% |
| 2011-03-03 00:44 | 2011-03-01 | DRISCOLL JOHN PATRICK | Officer - President - New Markets | OPT+S | $62.50 | 33,166 | $2,072,875 | 86,749 | 0.0% |
| 2011-03-03 00:44 | 2011-02-28 | Kornwasser Laizer | Officer - SVP-Retail, Mail & Diabetes | OPT+S | $62.50 | 22,961 | $1,435,164 | 61,169 | 0.0% |
| 2011-03-03 00:44 | 2011-02-28 | FITZPATRICK STEVEN R | Officer - Pres, Accredo Health, Inc. | OPT+S | $62.07 | 117,585 | $7,297,984 | 98,323 | 0.0% |
| 2011-03-02 00:43 | 2011-02-28 | PRINCIVALLE KARIN | Officer - SVP, Human Resources | OPT+S | $62.01 | 35,220 | $2,183,992 | 48,300 | 0.0% |
| 2011-03-02 00:43 | 2011-02-28 | SMITH JACK ALLEN | Officer - SVP, Chief Marketing Officer | OPT+S | $62.03 | 26,440 | $1,640,028 | 75,417 | 0.0% |
| 2011-03-02 00:43 | 2011-02-28 | DRISCOLL JOHN PATRICK | Officer - President - New Markets | SELL | $62.42 | 9,200 | $574,264 | 86,749 | -9.6% |
| 2011-02-25 00:36 | 2011-02-23 | Moriarty Thomas M | Officer - Gen'l Counsel & Secretary, SVP | SELL | $61.14 | 7,992 | $488,631 | 53,267 | -13.0% |
| 2011-02-25 00:36 | 2011-02-23 | Kornwasser Laizer | Officer - SVP-Retail, Mail & Diabetes | SELL | $61.13 | 7,106 | $434,390 | 51,419 | -12.1% |
| 2011-02-25 00:36 | 2011-02-23 | DRISCOLL JOHN PATRICK | Officer - President - New Markets | SELL | $61.83 | 9,589 | $592,888 | 82,949 | -10.4% |
| 2011-01-19 00:11 | 2011-01-13 | GRIFFIN BRIAN T | Officer - CEO, Medco Celesio BV | OPT+S | $65.00 | 206,358 | $13,413,270 | 99,349 | 0.0% |
| 2011-01-19 00:11 | 2011-01-13 | KLEPPER KENNETH O | Officer - President-Chief Oper. Officer | OPT+S | $65.00 | 148,938 | $9,680,970 | 187,901 | 0.0% |
| 2011-01-05 17:08 | 2011-01-03 | WILSON BLENDA J | Director | OPT+S | $61.27 | 3,500 | $214,445 | 28,900 | 0.0% |
| 2010-12-03 00:04 | 2010-12-01 | GRIFFIN BRIAN T | Officer - CEO, Medco Celesio BV | SELL | $62.00 | 17,111 | $1,060,882 | 99,349 | -14.7% |
| 2010-12-03 00:04 | 2010-12-01 | Moriarty Thomas M | Officer - Gen'l Counsel & Secretary, SVP | SELL | $61.75 | 4,828 | $298,129 | 71,295 | -6.3% |
| 2010-11-24 00:26 | 2010-11-22 | Moriarty Thomas M | Officer - Gen'l Counsel & Secretary, SVP | OPT+S | $61.00 | 33,678 | $2,054,358 | 80,295 | 0.0% |
| 2010-11-18 00:03 | 2010-11-16 | WENTWORTH TIMOTHY C | Officer - Group Pres, Employer Accounts | OPT+S | $59.30 | 79,455 | $4,711,650 | 95,915 | 0.0% |
| 2010-11-17 00:03 | 2010-11-16 | SMITH JACK ALLEN | Officer - SVP, Chief Marketing Officer | SELL | $59.48 | 2,754 | $163,799 | 78,726 | -3.4% |
| 2010-11-11 00:06 | 2010-11-08 | RUBINO RICHARD J | Officer - SVP, Finance & CFO | OPT+S | $60.00 | 42,913 | $2,574,780 | 62,041 | 0.0% |
| 2010-11-11 00:07 | 2010-11-08 | SNOW DAVID B JR | Director, Officer - Chairman and CEO | OPT+S | $60.00 | 385,200 | $23,113,579 | 224,204 | 0.0% |
| 2010-11-11 00:06 | 2010-11-08 | CASSIS JOHN L | Director | OPT+S | $60.00 | 16,000 | $960,000 | 26,400 | 0.0% |
| 2010-11-09 00:14 | 2010-11-05 | Moriarty Thomas M | Officer - Gen'l Counsel & Secretary, SVP | OPT+S | $59.25 | 47,176 | $2,795,202 | 80,295 | 0.0% |
| 2010-11-05 21:50 | 2010-11-04 | PRINCIVALLE KARIN | Officer - SVP, Human Resources | OPT+S | $12.81 | 33,112 | $424,231 | 44,156 | 0.0% |
| 2010-11-03 23:36 | 2010-11-02 | WILSON BLENDA J | Director | OPT+S | $58.00 | 3,750 | $217,500 | 28,900 | 0.0% |
| 2010-09-24 23:53 | 2010-09-22 | DRISCOLL JOHN PATRICK | Officer - President - New Markets | OPT+S | $50.00 | 142,705 | $7,135,578 | 98,039 | 0.0% |
| 2010-09-24 23:53 | 2010-09-22 | Kornwasser Laizer | Officer - SVP, Channel & Generic Stratg. | OPT+S | $50.01 | 37,945 | $1,897,462 | 62,619 | 0.0% |
| 2010-05-27 15:45 | 2010-05-25 | CASSIS JOHN L | Director | SELL | $55.00 | 1,400 | $77,000 | 26,400 | -5.0% |
| 2010-05-14 23:25 | 2008-10-07 | GOLDSTEIN MICHAEL | Director | BUY | $42.83 | 206 | $8,823 | 206 | +100.0% |
| 2010-03-19 23:10 | 2010-03-18 | WENTWORTH TIMOTHY C | Officer - Group Pres, Employer Accounts | OPT+S | $65.00 | 14,678 | $954,070 | 102,803 | 0.0% |
| 2010-03-13 00:08 | 2010-03-11 | GRIFFIN BRIAN T | Officer - Group President, Health Plans | SELL | $64.00 | 12,081 | $773,184 | 122,755 | -9.0% |
| 2010-03-06 00:20 | 2010-03-04 | PRINCIVALLE KARIN | Officer - SVP, Human Resources | SELL | $62.90 | 8,835 | $555,722 | 54,956 | -13.8% |
| 2010-03-02 23:58 | 2010-02-26 | DRISCOLL JOHN PATRICK | Officer - President - New Markets | SELL | $62.72 | 15,336 | $961,874 | 126,119 | -10.8% |
| 2010-03-02 23:58 | 2010-03-01 | PRINCIVALLE KARIN | Officer - SVP, Human Resources | SELL | $63.21 | 20,621 | $1,303,354 | 63,791 | -24.4% |
| 2010-03-02 23:58 | 2010-03-01 | EPSTEIN ROBERT S | Officer - SVP Medical Affairs & CMO | OPT+S | $64.00 | 51,440 | $3,292,160 | 157,491 | 0.0% |
| 2010-03-02 23:58 | 2010-03-01 | Cappucci Gabriel R. | Officer - SVP, Contr & Chief Acct. Off. | OPT+S | $63.05 | 12,136 | $765,159 | 19,630 | 0.0% |
| 2010-03-02 23:58 | 2010-02-26 | Kornwasser Laizer | Officer - SVP, Channel & Generic Stratg. | SELL | $62.72 | 7,847 | $492,164 | 67,699 | -10.4% |
| 2010-03-02 23:58 | 2010-03-01 | GOLDSTEIN MICHAEL | Director | OPT+S | $63.05 | 16,000 | $1,008,800 | 27,800 | 0.0% |
| 2010-03-02 23:57 | 2010-03-01 | CASSIS JOHN L | Director | OPT+S | $63.08 | 16,000 | $1,009,280 | 27,800 | 0.0% |
| 2010-03-01 22:51 | 2010-02-25 | WENTWORTH TIMOTHY C | Officer - Group Pres, Employer Accounts | SELL | $62.44 | 9,829 | $613,723 | 89,413 | -9.9% |
| 2009-12-01 21:03 | 2009-11-30 | GRIFFIN BRIAN T | Officer - Group President, Health Plans | SELL | $63.07 | 118,208 | $7,454,941 | 127,090 | -48.2% |
How to Interpret $MHS Trades
Not every insider transaction in MHS is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MHS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for MHS
Insider activity data for MHS is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MHS, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.